Authors/Disclosures
		
			| Aga J. Lewelt | No disclosure on file | 
		
			| Omar A. Danoun, MD
					(Henry Ford Hospital) | Dr. Danoun has nothing to disclose. | 
		
			| Adam Witt, MD
					(University of Alberta Hospital) | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| John T. Kissel, MD, FAAN | Dr. Kissel has nothing to disclose. | 
		
			| Thomas O. Crawford, MD
					(Johns Hopkins Hospital) | Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. | 
		
			| Gyula Acsadi, MD, FAAN
					(Connecticut Children'S Medical Center/UConn) | Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. | 
		
			|  | No disclosure on file | 
		
			| Bakri Elsheikh, MD, FAAN
					(The Ohio State University Wexner Medical Center) | Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex .  The institution of Dr. Elsheikh has received research support from Biogen.  The institution of Dr. Elsheikh has received research support from Cure SMA. | 
		
			| Sandra P. Reyna, MD | Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies. | 
		
			|  | No disclosure on file | 
		
			| Mary K. Schroth, MD | Dr. Schroth has received personal compensation for serving as an employee of Cure SMA.  The institution of Dr. Schroth has received research support from Biogen. | 
		
			| Louise R. Simard, PhD
					(University of Manitoba) | No disclosure on file | 
		
			|  | No disclosure on file | 
		
			| Kathryn J. Swoboda, MD | Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.  The institution of Dr. Swoboda has received research support from Biogen. |